According to a new market report published by Transparency Market Research “Tuberculosis Testing Market (Smear Microscopy, Culture Based Tests, Nucleic Acid Testing, Mantoux Test, Radiography (Chest X-Ray), Drug Susceptibility Testing (DST) and Other TB Tests): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020,” the global tuberculosis testing market was valued at USD 1,936.1 million in 2013 and is expected to grow at a CAGR of 4.3% from 2014 to 2020, to reach an estimated value of USD 2,619.4 million in 2020.
The tuberculosis testing market comprises of diagnostic tests, equipment and testing procedures that assist in diagnosis of tuberculosis infection. The global market for tuberculosis testing has been segmented into four major regional markets – North America, Europe, Asia Pacific, and Rest of the World (RoW). Asia Pacific accounted for the largest share of the overall tuberculosis testing market in 2013 followed by North America. According to the World Health Organization (WHO) estimates, 8.6 million cases of TB were registered globally in 2012 that further increased to approximately 9 million cases in 2013. The WHO also estimated that among the global TB patient pool, 1.3 million patients died in 2012, which further increased in 2013 with 1.5 million deaths. More than 95% of TB deaths occur in low to medium income countries. At present, a large number of TB related deaths have been found to be associated with HIV infections. According to the estimates, in 2012, approximately 320,000 TB deaths occurred among HIV positive TB patients worldwide. The WHO also estimated that around 480,000 individuals developed multi-drug-resistant (MDR) TB in 2013 globally. However, due to ongoing TB diagnosis and treatment programs, an estimated 37 million lives were saved during the period from 2000 to 2013.
Asia Pacific is the largest regional market for TB testing in terms of revenue and accounted for a share of more than 36.0% of the global market in 2013, followed by North America. Dominance of Asia Pacific in the global TB market has been majorly attributed to the presence of a vast patient pool, which is increasing at a rapid pace due to very high incidence rates of the disease especially in some of the emerging economies such as India and China. TB tests that significantly contribute towards growth of the Asia Pacific TB testing market include nucleic acid tests, culture based tests, chest radiography, smear microscopy and Mantoux test. Among these, nucleic acid tests was the largest contributor towards the overall Asia Pacific TB testing market followed by culture based tests, chest radiography, smear microscopy and Mantoux tests in 2013.
In contrast, North America has a relatively smaller patient pool with lower disease incidences. High awareness, well developed healthcare infrastructure, high acceptance of improved but expensive TB tests and better purchasing power are contributing towards North America’s relatively higher market share compared to Europe and RoW. Some of the most common types of TB tests that are widely preferred over other tests in North America include Mantoux test (tuberculin skin tests or TST) and culture (solid or liquid) based TB tests. North America was the second largest regional market for TB tests after Asia Pacific with most of its revenues coming from Mantoux tests (TST). Europe was the third largest market for tuberculosis testing in terms of revenue in 2013. Major Western European economies such as the U.K., Germany, France, Spain and Italy are the key contributing nations towards the overall tuberculosis testing market revenue in Europe in 2013. In Europe, TB testing procedures such as culture based TB diagnostic tests are observed to be preferred more over other TB testing procedures.
Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche, Ltd., Hain Lifescience GmbH, bioMérieux SA, Hologic, Inc., QIAGEN, Akonni Biosystems, Inc., Abbott Laboratories, Alere, Inc., Cepheid, Epistem, Plc. and Sanofi are some of the major players operating in the global tuberculosis testing market. Among these Becton, Dickinson and Company or BD, Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche Ltd. and Hain Lifescience GmbH lead this market.
The global tuberculosis testing market is segmented as follows:
Global Tuberculosis Testing Market, by Test Type
- Smear Microscopy
- Culture Based Tests
- Nucleic Acid Testing
- Mantoux Test (Tuberculin Skin Test)
- Radiography (Chest X-Ray)
- Drug Susceptibility Testing (DST)
- Other Tests (Serological Tests, IGRA, ADA, etc.)
- North America
- Asia Pacific
- Rest of the World (RoW)